Doctor hits FDA on Epogen oversight
He says dialysis patients at risk from anemia drug
A Boston researcher whose clinical trial linked aggressive use of anemia drugs to an increased risk of fatal heart attacks and strokes says the government is not doing enough to protect dialysis patients from the potential dangers. (Full article: 836 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
